FTC challenges ‘bogus' patents on Ozempic, other drugs that ‘block competition'Market Watch • 04/30/24
GSK (GSK) Registers a Bigger Fall Than the Market: Important Facts to NoteZacks Investment Research • 04/02/24
GSK PLC Sponsored ADR (GSK) is Attracting Investor Attention: Here is What You Should KnowZacks Investment Research • 03/28/24
Sosei Heptares Regains Full Ownership from GSK of HTL0027477, a Clinic-ready, First-in-Class Oral GPR35 Agonist for Inflammatory Bowel DiseaseGlobeNewsWire • 03/21/24
GSK (GSK) Increases Yet Falls Behind Market: What Investors Need to KnowZacks Investment Research • 03/19/24